Search

Author/Creator Hartog, Mitch

1. Pharmacological validation of TDO as a target for Parkinson's disease. (18th February 2021)

Authors:
Perez‐Pardo, Paula; Grobben, Yvonne; Willemsen‐Seegers, Nicole; Hartog, Mitch; Tutone, Michaela; Muller, Michelle; Adolfs, Youri; Pasterkamp, Ronald Jeroen; Vu‐Pham, Diep; van Doornmalen, Antoon M.; van Cauter, Freek; de Wit, Joeri; Gerard Sterrenburg, Jan; Uitdehaag, Joost C.M.; de Man, Jos; Bui...
Journal:
FEBS journal
Issue:
Volume 288:Number 14(2021)
Page Start:
4311
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder. (May 2022)

Authors:
Dijkstra, Francis M; van de Loo, Aurora JAE; Abdulahad, Smedra; Bosma, Else R; Hartog, Mitch; Huls, Hendrikje; Kuijper, Dianne C; de Vries, Esther; Solanki, Bhavna; Singh, Jaskaran; Aluisio, Leah; Zannikos, Peter; Stuurman, Frederik E; Jacobs, Gabriël E; Verster, Joris C
Journal:
Journal of psychopharmacology
Issue:
Volume 36:Number 5(2022)
Page Start:
614
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search